Traditional and personalised models of therapy in gastrointestinal and endocrine tumours: the role of histological and clinical markers

Bookmark and Share
Sorry, this item is currently unavailable.
Published: 8 Nov 2013
Views: 3482
Rating:
Save
Dr Jaume Capdevila - Vall d'Hebron University Hospita, Barcelona, Spain

Speaking at the AstraZeneca sponsored satellite symposium 'The revolution in peronalised healthcare: Towards improved outcomes in oncology', at the 2013 European Cancer Congress, Dr Capdevila discusses the role of histological and clinical markers in the modern field of personalised care for GI and endocrine tumours.